Amphastar Pharmaceuticals Inc (AMPH)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current AMPH market cap is 1.49B. The company's latest EPS is USD 2.8607 and P/E is 10.84.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 180.56M | 178.11M | 171.84M | 182.39M | 191.21M |
| Operating Income | 72.68M | 53.98M | 48.01M | 55.22M | 57.05M |
| Net Income | 49.22M | 36.17M | 43.18M | 37.95M | 40.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 322.36M | 349.85M | 437.77M | 498.99M | 644.4M |
| Operating Income | -39k | 10.95M | 69.68M | 106.32M | 196.99M |
| Net Income | 48.94M | 1.4M | 62.12M | 91.39M | 137.55M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.54B | 1.51B | 1.57B | 1.49B | 1.55B |
| Total Liabilities | 949.49M | 873.49M | 901.96M | 778.18M | 817.5M |
| Total Equity | 595.14M | 639.42M | 672.36M | 713.35M | 727.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 586.97M | 631.24M | 671.53M | 741.99M | 1.51B |
| Total Liabilities | 159.44M | 182.51M | 226.01M | 213.33M | 873.49M |
| Total Equity | 427.53M | 448.72M | 445.52M | 528.66M | 639.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 159.64M | 183.5M | 55.29M | 124.4M | 184.36M |
| Investing | -546.07M | -649.12M | 15.24M | -54.67M | -89.25M |
| Financing | 501.18M | 454.09M | -13.58M | -24.3M | -47.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 41.76M | 57.27M | 97.99M | 89.18M | 183.5M |
| Investing | -50.53M | -36.42M | -28.67M | -32.78M | -649.12M |
| Financing | -3.78M | -2.25M | -37.02M | -26.44M | 454.09M |
| Market Cap | 1.49B |
| Price to Earnings Ratio | 10.84 |
| Price to Sales Ratio | 2.31 |
| Price to Cash Ratio | 10.33 |
| Price to Book Ratio | 2.33 |
| Dividend Yield | - |
| Shares Outstanding | 48.08M |
| Average Volume (1 week) | 347.17k |
| Average Volume (1 Month) | 418.43k |
| 52 Week Change | -43.88% |
| 52 Week High | 56.38 |
| 52 Week Low | 31.00 |
| Spread (Intraday) | 1.18 (3.78%) |
| Company Name | Amphastar Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.amphastar.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
